105 related articles for article (PubMed ID: 7692555)
1. The amino-terminus of substance P mimics and MK-801 attenuates the effects of capsaicin on nociception and kainic acid-induced behavior in the mouse.
Larson AA; Sun X
Regul Pept; 1993 Jul; 46(1-2):421-3. PubMed ID: 7692555
[No Abstract] [Full Text] [Related]
2. MK-801 inhibits the effects of capsaicin in the adult mouse by an action involving phencyclidine (PCP) sites not linked to NMDA activity.
Sun X; Larson AA
Neuroreport; 1993 Sep; 4(10):1147-50. PubMed ID: 7693010
[TBL] [Abstract][Full Text] [Related]
3. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity.
Larson AA; Sun X
Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172
[TBL] [Abstract][Full Text] [Related]
4. MK-801 and phencyclidine act at phencyclidine sites that are not linked to N-methyl-D-aspartate activity to inhibit behavioral sensitization to kainate.
Sun X; Larson AA
Neuroscience; 1993 Jun; 54(3):773-9. PubMed ID: 8101361
[TBL] [Abstract][Full Text] [Related]
5. Activity at phencyclidine and mu opioid sites mediates the hyperalgesic and antinociceptive properties of the N-terminus of substance P in a model of visceral pain.
Goettl VM; Larson AA
Neuroscience; 1994 May; 60(2):375-82. PubMed ID: 7521022
[TBL] [Abstract][Full Text] [Related]
6. Kynurenic acid blocks chemogenic nociception.
Hajós M; Engberg G
J Pharm Pharmacol; 1990 May; 42(5):373-4. PubMed ID: 1976793
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists.
Eriksson C; Zou LP; Ahlenius S; Winblad B; Schultzberg M
Brain Res Mol Brain Res; 2000 Dec; 85(1-2):103-13. PubMed ID: 11146112
[TBL] [Abstract][Full Text] [Related]
8. Involvement of spinal NK2 and NMDA receptors in aversive behavior induced by intra-arterial injection of capsaicin.
Ando R; Watanabe C; Kawamura S; Yonezawa A; Sakurada T
Pharmacol Biochem Behav; 2001 Jan; 68(1):105-13. PubMed ID: 11274715
[TBL] [Abstract][Full Text] [Related]
9. A comparative analysis of the neuroprotective properties of competitive and uncompetitive N-methyl-D-aspartate receptor antagonists in vivo: implications for the process of excitotoxic degeneration and its therapy.
Massieu L; Thedinga KH; McVey M; Fagg GE
Neuroscience; 1993 Aug; 55(4):883-92. PubMed ID: 7694181
[TBL] [Abstract][Full Text] [Related]
10. Evoked endogenous taurine release from cultured cerebellar neurons.
Dutton GR; Rogers KL
Adv Exp Med Biol; 1992; 315():269-76. PubMed ID: 1380760
[No Abstract] [Full Text] [Related]
11. The NMDA receptor antagonist MK-801 reduces capsaicin-induced c-fos expression within rat trigeminal nucleus caudalis.
Mitsikostas DD; Sanchez del Rio M; Waeber C; Moskowitz MA; Cutrer FM
Pain; 1998 May; 76(1-2):239-48. PubMed ID: 9696479
[TBL] [Abstract][Full Text] [Related]
12. Antinociception induced by 3-((+-)-2-carboxypiperazin-4-yl)-propyl-1- phosphonic acid (CPP), an N-methyl-D-aspartate (NMDA) competitive antagonist, plus 6,7-dinitroquinoxaline-2,3-dione (DNQX), a non-NMDA antagonist, differs from that induced by MK-801 plus DNQX.
Goettl VM; Larson AA
Brain Res; 1994 Apr; 642(1-2):334-8. PubMed ID: 8032897
[TBL] [Abstract][Full Text] [Related]
13. NMDA receptors are involved in the antidepressant-like effects of capsaicin following amphetamine withdrawal in male mice.
Amiri S; Alijanpour S; Tirgar F; Haj-Mirzaian A; Amini-Khoei H; Rahimi-Balaei M; Rastegar M; Ghaderi M; Ghazi-Khansari M; Zarrindast MR
Neuroscience; 2016 Aug; 329():122-33. PubMed ID: 27167081
[TBL] [Abstract][Full Text] [Related]
14. The role of neurokinin and N-methyl-D-aspartate receptors in synaptic transmission from capsaicin-sensitive primary afferents in the rat spinal cord in vitro.
Nagy I; Maggi CA; Dray A; Woolf CJ; Urban L
Neuroscience; 1993 Feb; 52(4):1029-37. PubMed ID: 7680798
[TBL] [Abstract][Full Text] [Related]
15. Enhanced nociception by exogenous and endogenous substance P given into the spinal cord in mice lacking NR(2)A/epsilon(1), an NMDA receptor subunit.
Inoue M; Mishina M; Ueda H
Br J Pharmacol; 2000 Jan; 129(2):239-41. PubMed ID: 10694228
[TBL] [Abstract][Full Text] [Related]
16. Descending systems activated by morphine (ICV) inhibit kainic acid (IT)-induced behavior.
DeLander GE; Wahl JJ
Pharmacol Biochem Behav; 1991 May; 39(1):155-9. PubMed ID: 1718010
[TBL] [Abstract][Full Text] [Related]
17. ACTH4-10, substance P, and dizolcipine (MK-801) accelerate functional recovery after hemilabyrinthectomy in goldfish.
Mattioli R; Huston JP; Spieler RE
Neural Plast; 2000; 7(4):291-301. PubMed ID: 11486488
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of a behavioural response in mice by spinal coadministration of substance P and excitatory amino acid agonists.
Mjellem-Joly N; Lund A; Berge OG; Hole K
Neurosci Lett; 1991 Nov; 133(1):121-4. PubMed ID: 1724310
[TBL] [Abstract][Full Text] [Related]
19. beta-Amyloid (25-35) or substance P stimulates [3H]MK-801 binding to rat cortical membranes in the presence of glutamate and glycine.
Calligaro DO; O'Malley PJ; Monn JA
J Neurochem; 1993 Jun; 60(6):2297-303. PubMed ID: 7684071
[TBL] [Abstract][Full Text] [Related]
20. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism.
Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K
Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
